The Epidemiology of Epilepsy.

Neuroepidemiology. 54: 185-191

Interactions between hormones and epilepsy | Elsevier Enhanced Reader. doi:10.1016/j.seizure.2015.02.012

Logothetis J. Harner R. Morrell F. et al.

The role of estrogens in catamenial exacerbation of epilepsy.

Neurology. 9: 352

Neuroendocrine considerations in the treatment of men and women with epilepsy.

Lancet Neurol. 12: 72-83Herzog A.G. Mandle H.B. MacEachern D.B.

Does the age of seizure onset relate to menarche and does it matter?.

Seizure. 69: 1-6

Epilepsy and other chronic convulsive diseases: their causes, symptoms, and treatment.

Forgotten Books, London, UKVélez-Ruiz N.J. Pennell P.B.

Issues for Women with Epilepsy.

Neurol Clin. 34 (): 411-425

Women’s Issues in Epilepsy.

Contin Minneap Minn. 28: 399-427Herzog A.G. Fowler K.M. Smithson S.D. et al.

Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Neurology. 78: 1959-1966Mattson R.H. Cramer J.A. Caldwell B.V. et al.

Treatment of seizures with medroxyprogesterone acetate: preliminary report.

Neurology. 34: 1255-1258

Acetazolamide in Treatment of Epilepsy.

Br Med J. 1: 650-654Feely M. Calvert R. Gibson J.

Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants.

Lancet Lond Engl. 2: 71-73Verrotti A. D’Egidio C. Coppola G. et al.

Epilepsy, sex hormones and antiepileptic drugs in female patients.

Expert Rev Neurother. 9: 1803-1814Svalheim S. Sveberg L. Mochol M. et al.

Interactions between antiepileptic drugs and hormones.

Seizure. 28: 12-17Artama M. Isojärvi J.I.T. Raitanen J. et al.

Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland.

Am J Epidemiol. 159: 1057-1063

Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences.

Epilepsia. 35: 750-756Löfgren E. Pouta A. von Wendt L. et al.

Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility.

Epilepsy Behav EB. 14: 102-107Pennell P.B. French J.A. Harden C.L. et al.

Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.

JAMA Neurol. 75: 962-969Stephen L.J. Harden C. Tomson T. et al.

Management of epilepsy in women.

Lancet Neurol. 18: 481-491Herzog A.G. Mandle H.B. Cahill K.E. et al.

Predictors of unintended pregnancy in women with epilepsy.

Neurology. 88: 728-733Herzog A.G. Mandle H.B. Cahill K.E. et al.

Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry.

Epilepsia. 57: 630-637Herzog A.G. Blum A.S. Farina E.L. et al.

Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use.

Neurology. 72: 911-914Tomson T. Battino D. Bromley R. et al.

Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy.

Epileptic Disord Int Epilepsy J Videotape. 21: 497-517

The Teratogenicity of Anticonvulsant Drugs.

N Engl J Med. 344: 1132-1138

Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?.

Epilepsia. 49: 43-55de Jong J. Garne E. de Jong-van den Berg L.T.W. et al.

The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review.

Drugs - Real World Outcomes. 3: 131-143Veroniki A.A. Cogo E. Rios P. et al.

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.

BMC Med. 15: 95Weston J. Bromley R. Jackson C.F. et al.

Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

Cochrane Database Syst Rev. 11: CD010224Tomson T. Battino D. Perucca E.

Teratogenicity of antiepileptic drugs.

Curr Opin Neurol. 32: 246-252Hernandez-Diaz S. Huybrechts K.F. Desai R.J. et al.

Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study.

Neurology. 90: e342-e351

Annual Update for 2022 – AED.

() ()Meador K.J. Pennell P.B. May R.C. et al.

Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.

Epilepsy Behav EB. 84: 10-14Keni R.R. Jose M. Sarma P.S. et al.Kerala Registry of Epilepsy and Pregnancy Study Group

Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both?.

Neurology. 90: e790-e796Hernández-Díaz S. McElrath T.F. Pennell P.B. et al.

Fetal growth and premature delivery in pregnant women on antiepileptic drugs.

Ann Neurol. 82: 457-465Van Marter L.J. Pennell P.B. Brown C. et al.

Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy.

J Pediatr X. 7: 100073Meador K.J. Baker G.A. Browning N. et al.

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Lancet Neurol. 12: 244-252Elkjær L.S. Bech B.H. Sun Y. et al.

Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children.

JAMA Neurol. 75: 663-671Christensen J. Grønborg T.K. Sørensen M.J. et al.

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

JAMA. 309: 1696-1703Daugaard C.A. Pedersen L. Sun Y. et al.

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.

JAMA Netw Open. 3: e2025570Christensen J. Pedersen L. Sun Y. et al.

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.

JAMA Netw Open. 2: e186606Bjørk M.H. Zoega H. Leinonen M.K. et al.

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.

JAMA Neurol. https://doi.org/10.1001/jamaneurol.2022.1269Meador K.J. Cohen M.J. Loring D.W. et al.

Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study.

JAMA Neurol. 78: 927-936Bjørk M. Riedel B. Spigset O. et al.

Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero.

JAMA Neurol. 75: 160-168Reisinger T.L. Newman M. Loring D.W. et al.

Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.

Epilepsy Behav EB. 29: 13-18Pennell P.B. French J.A. May R.C. et al.

Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.

N Engl J Med. 383: 2547-2556Edey S. Moran N. Nashef L.

SUDEP and epilepsy-related mortality in pregnancy.

Epilepsia. 55: e72-e74MacDonald S.C. Bateman B.T. McElrath T.F. et al.

Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States.

JAMA Neurol. 72: 981-988Polepally A.R. Pennell P.B. Brundage R.C. et al.

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

Ann Clin Transl Neurol. 1: 99-106

Meeting the needs of the postpartum woman with epilepsy.

MCN Am J Matern Child Nurs. 33: 84-89

Women with epilepsy: a practical management handbook.

Cambridge University Press, https://doi.org/10.1017/CBO9781139178020Harden C.L. Pennell P.B. Koppel B.S. et al.

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Neurology. 73: 142-149Meador K.J. Baker G.A. Browning N. et al.

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

JAMA Pediatr. 168: 729-736Birnbaum A.K. Meador K.J. Karanam A. et al.

Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy.

JAMA Neurol. 77: 441-450Harden C.L. Koppel B.S. Herzog A.G. et al.

Seizure frequency is associated with age at menopause in women with epilepsy.

Neurology. 61: 451-455Harden C.L. Pulver M.C. Ravdin L. et al.

The effect of menopause and perimenopause on the course of epilepsy.

Epilepsia. 40: 1402-1407Harden C.L. Herzog A.G. Nikolov B.G. et al.

Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.

Epilepsia. 47: 1447-1451

Gender Disparities in Osteoporosis.

J Clin Med Res. 9: 382-387

Bone health in women with epilepsy: clinical features and potential mechanisms.

Int Rev Neurobiol. 83: 305-328

Special Issues in Epilepsy: The Elderly, the Immunocompromised, and Bone Health.

Contin Minneap Minn. 22: 246-261